Hannele
Hannele Hevosmaa, Kajaani FI
Patent application number | Description | Published |
---|---|---|
20110277667 | TALC FOR PAINT PRODUCTS AND METHOD OF MAKING THE SAME - A talc slurry and a method of producing the talc slurry. A talc product includes the talc slurry having total solids (TS) 40% or higher and a dispersant agent and/or a thickener. | 11-17-2011 |
Hannele Kuosa, Espoo FI
Patent application number | Description | Published |
---|---|---|
20120227633 | MATERIAL TO BE USED AS A CONCRETE ADDITIVE - The invention relates to an admixture for a cementitious composition comprising microfibrillar cellulose and/or a derivative thereof. The invention also relates to a method of manufacturing said admixture and to the use of the microfibrillar cellulose and/or a derivative thereof in the concrete admixture. The invention further relates to a cementitious composition comprising said admixture and methods of manufacture and use thereof. | 09-13-2012 |
Hannele Ruohoa-Baker, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20150337332 | Methods and Compositions to Modulate RNA Processing - The present disclosure provides methods and compositions to selectively modulate RNA processing. The methods and compositions selectively enhance or repress RNA processing by up- or down-regulating Drosha expression and/or by providing RNA sequences with mis-matches introduced or removed 5 and/or 9-12 nucleotide positions from the Drosha cutting site. Therapeutic uses of the methods and compositions are also described. | 11-26-2015 |
Hannele Ruohola-Baker, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20140051729 | COMPOSITIONS AND METHODS FOR TREATING DEGENERATIVE MUSCLE CONDITIONS - Methods and compositions for treating degenerative muscle conditions are disclosed. The compositions disclosed herein include S1P promoting compositions that include an S1P promoting agent. Embodiments of the methods disclosed herein include administering therapeutically effective amounts to subjects suffering from a degenerative muscle condition, such as, for example, subjects suffering from sarcopenia and subjects suffering from muscular dystrophy, including subjects suffering from Duchenne Muscular Dystrophy and Becker Muscular Dystrophy. | 02-20-2014 |